Search
News
Important Only
Other
IBio Received Regulatory Clearance To Initiate Its Phase 1 Clinical Trial Of Ibio-600 In Australia
April 8 (Reuters) - iBio Inc IBIO.O:IBIO RECEIVED REGULATORY CLEARANCE TO INITIATE ITS PHASE 1 CLINICAL TRIAL OF IBIO-600 IN AUSTRALIAIBIO INC - PHASE 1 TRIAL OF IBIO-600 TO BEGIN DOSING IN Q2 2026Reuters
Wed, Apr 8
Other
Factset Announces Chief Financial Officer Transition
April 8 (Reuters) - Factset Research Systems Inc FDS.N:FACTSET ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITIONFACTSET - APPOINTS JOSHUA B. WARREN AS CFO EFFECTIVE APRIL 13, 2026FACTSET - JOSHUA B. WARREN TO SUCCEED HELEN SHAN AS CFOReuters
Wed, Apr 8
Other
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
April 8 (Reuters) - BioXcel Therapeutics Inc BTAI.O:BIOXCEL THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENTS IN U.S. DEPARTMENT OF WAR-FUNDED STUDY OF BXCL501 (SUBLINGUAL DEXMEDETOMIDINE) FOR TREATMENT OF ACUTE STRESS REACTIONSReuters
Wed, Apr 8
Other
Bleichroeder Acquisition Corp Ii - Pasqal Announces Strategic Collaboration With True Nexus For Food Protein Design
April 8 (Reuters) - Bleichroeder Acquisition Corp II BBCQ.O:BLEICHROEDER ACQUISITION CORP II - PASQAL ANNOUNCES STRATEGIC COLLABORATION WITH TRUE NEXUS FOR FOOD PROTEIN DESIGNBLEICHROEDER ACQUISITION CORP II - PASQAL PLANS TO GO PUBLIC VIA COMBINATION WITH BLEICHROEDER ACQUISITION CORP. IIReuters
Wed, Apr 8
Other
Sidewinder Therapeutics Announces $137 Million Series B Financing To Advance Precision Bispecific ADCs Into Clinical Development For Cancer
April 8 (Reuters) - SIDEWINDER THERAPEUTICS ANNOUNCES $137 MILLION SERIES B FINANCING TO ADVANCE PRECISION BISPECIFIC ADCS INTO CLINICAL DEVELOPMENT FOR CANCERSIDEWINDER THERAPEUTICS: FINANCING CO-LED BY FRAZIER LIFE SCIENCES AND NOVARTIS VENTURE FUNDSIDEWINDER THERAPEUTICS: FINANCING WITH PARTICIPA...Reuters
Wed, Apr 8
Other
Atkore Inc. Announces Sale Of Hdpe Pipe & Conduit Business To Infra Pipes
April 8 (Reuters) - Atkore Inc ATKR.N:ATKORE INC. ANNOUNCES SALE OF HDPE PIPE & CONDUIT BUSINESS TO INFRA PIPESATKORE INC - TO CAPITALIZE COMBINED BUSINESS WITH $28 MILLION AND RETAIN 10% EQUITY STAKEATKORE INC - EXPECTS TO ACHIEVE TAX BENEFITS FROM SALE OF HDPE BUSINESSATKORE INC - DEAL EXPECTE...Reuters
Wed, Apr 8
Other
Bed Bath & Beyond To Acquire Lumber Liquidators, Cabinets To Go, And Other F9 Brand Assets, Expanding National Home Services Platform
April 8 (Reuters) - Bed Bath & Beyond Inc BBBY.N:BED BATH & BEYOND TO ACQUIRE LUMBER LIQUIDATORS, CABINETS TO GO, AND OTHER F9 BRAND ASSETS, EXPANDING NATIONAL HOME SERVICES PLATFORMBED BATH & BEYOND TO ACQUIRE LUMBER LIQUIDATORS, CABINETS TO GO, AND OTHER F9 BRAND ASSETS, EXPANDING NATI...Reuters
Wed, Apr 8
Other
Hot Chili Confirms Major High-Grade Extension At La Verde From Standout Drill Result Of 62 M @ 1.03% Cueq¹ Within 725 M @ 0.42% Cueq¹ From 18 M Depth
April 8 (Reuters) - Hot Chili Ltd HCH.AX:HOT CHILI CONFIRMS MAJOR HIGH-GRADE EXTENSION AT LA VERDE FROM STANDOUT DRILL RESULT OF 62 M @ 1.03% CUEQ¹ WITHIN 725 M @ 0.42% CUEQ¹ FROM 18 M DEPTHReuters
Wed, Apr 8
Other
Unity And Meta Extend Multi‑Year Partnership To Power Next‑Generation Vr Experiences
April 8 (Reuters) - Unity Software Inc U.N:UNITY AND META EXTEND MULTI‑YEAR PARTNERSHIP TO POWER NEXT‑GENERATION VR EXPERIENCESUNITY SOFTWARE INC - TO CONTINUE SUPPORT FOR META'S VR PLATFORM UNDER EXTENDED PARTNERSHIPReuters
Wed, Apr 8
Other
United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For Miroliverelap® For Treatment Of Acute Liver Failure
United Therapeutics Corp UTHR.O:UNITED THERAPEUTICS RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY DESIGNATION FOR MIROLIVERELAP® FOR TREATMENT OF ACUTE LIVER FAILUREReuters
Wed, Apr 8
Other
Rezolve Ai PLC - Offers 1 Share For 2 Commerce.Com Shares
April 8 (Reuters) - Rezolve AI PLC O5F.F:REZOLVE AI PLC - OFFERS 1 SHARE FOR 2 COMMERCE.COM SHARESREZOLVE AI PLC - COMMERCE.COM SHAREHOLDERS OFFERED $5.50 IMPLIED VALUE PER SHAREREZOLVE AI PLC: OFFER FOLLOWS COMMERCE.COM BOARD'S REPEATED REFUSAL TO ENGAGE IN DEAL TALKSReuters
Wed, Apr 8
Other
Proqr Announces Partnership With Ginkgo Bioworks And Formation Of Ai Advisory Board
April 8 (Reuters) - ProQR Therapeutics NV PRQR.O:PROQR ANNOUNCES PARTNERSHIP WITH GINKGO BIOWORKS AND FORMATION OF AI ADVISORY BOARDPROQR THERAPEUTICS NV - EXPECTS FIRST AI-DISCOVERED DEVELOPMENT CANDIDATE TO ENTER CLINIC IN 2026PROQR THERAPEUTICS NV - GINKGO BIOWORKS MAKES STRATEGIC EQUITY INVESTME...Reuters
Wed, Apr 8
Featured Tools
Top News
SpaceX IPO Guide: Can You Buy SpaceX IPO Shares on Robinhood? How Can Investors in Asia and Europe Buy SpaceX IPO Shares?
Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October
Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock
IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?
Amazon Stock: 4 Pillars Supporting a Buy Thesis in a Cautious Market
Market Movers
Tradingkey
